Life-sciences real estate: More than an experiment
The surge in investment in life-sciences property in 2020 was not all about COVID-19, writes Rachel Fixsen
This content is only available Â鶹ӳ» Real Asset members
Already an Â鶹ӳ» Real Assets Member?
Unlock your Â鶹ӳ» Real Assets Membership Package
For access to Â鶹ӳ» Real Assets industry-leading market intelligence the leading information resource for the European institutional real assets investment community.
What type of organisation do you work for?
PropertyEU has now merged with Â鶹ӳ» Real Assets
Membership will give you full access to the PropertyEU archive.
If you have a PropertyEU membership find out how to get access.
Â鶹ӳ» Real Assets Membership
Â鶹ӳ» Real Assets has created a suite of products and services for Europe’s institutional real estate investment community.
Premium content
Pension fund interviews,
country analysis and data
country analysis and data
Opinion and analysis
Asset classes
and strategies in depth
and strategies in depth
Â鶹ӳ» covers a good variety of very current and relevant topics. It is good to read the high-level, independent and objective perspectives from pension funds in other European countries; many of them are dealing with the same issues as we are, so it is interesting to learn from their experiences, especially when they are ahead of where we are on the curve.
Copyright © 1997–2026 Â鶹ӳ», Registered in England, Reg No. 3233596, VAT No. 685 1784 92. Registered Office: 1 Kentish Buildings, 125 Borough High Street, London SE1 1NP